financetom
Business
financetom
/
Business
/
Emory University Doubles Down on Bitcoin With $52M Grayscale BTC ETF Stake
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Emory University Doubles Down on Bitcoin With $52M Grayscale BTC ETF Stake
Nov 13, 2025 8:59 AM

Emory University tiptoed further into bitcoin (BTC) during the third quarter.

The private research university based in Georgia reported holding over 1 million shares of the Grayscale Bitcoin Mini Trust as Sept. 30, according to a 13F filing Thursday. That stake was worth roughly nearly $52 billion at that time, though sizably less now at current prices. The school held just under 500,000 shares of the fund at the end of the second quarter.

The university first disclosed a position in Grayscale’s trust in October 2024, then valued at just over $15 million.

Emory's far smaller position in BlackRock's ( BLK ) spot bitcoin ETF was unchanged during the third quarter and valued at just about $290,000.

The endowment managers' interest in hard assets was also reflected in a new move into BlackRock's ( BLK ) iShares Gold Trust ( IAU ) , with nearly a $79 million stake in that fund as of the end of the third quarter.

The university’s endowment also modestly increased its equity stake in crypto exchange Coinbase (COIN). It now holds nearly 4,500 shares worth close to $1.2 million, up slightly from the 4,312 shares it’s held since last year.

Endowments are long-term investment funds typically set up to support non-profits like universities, hospitals or religious institutions. Like pension funds, they tend to favor relatively conservative strategies, which makes their increasing interest in bitcoin through regulated ETFs a noteworthy shift.

Emory’s broader embrace of bitcoin ETFs could be seen as part of a slow but steady thaw among institutional investors. While still a small piece of its overall portfolio, the size and pace of Emory’s bitcoin allocations signal a rising comfort level with the asset — especially when held in familiar wrappers like ETFs.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Synchrony Financial, Dick's Sporting Goods Agree to Multiyear Partnership Extension
Synchrony Financial, Dick's Sporting Goods Agree to Multiyear Partnership Extension
Sep 26, 2024
10:27 AM EDT, 09/26/2024 (MT Newswires) -- Synchrony Financial ( SYF ) and Dick's Sporting Goods (DKS) said Thursday they have agreed to a multiyear extension of their partnership for continued financial services to athletes. The companies said that through the Dick's Sporting Goods ScoreRewards Credit Card program, they will provide athletes with the ability to earn rewards twice faster,...
Appfolio Insider Sold Shares Worth $1,263,077, According to a Recent SEC Filing
Appfolio Insider Sold Shares Worth $1,263,077, According to a Recent SEC Filing
Sep 26, 2024
10:01 AM EDT, 09/26/2024 (MT Newswires) -- Maurice J Duca, 10% Owner, on September 23, 2024, sold 5,333 shares in Appfolio ( APPF ) for $1,263,077. Following the Form 4 filing with the SEC, Duca has control over a total of 213,623 shares of the company, with 9,383 shares held directly and 204,240 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1433195/000141588924023973/xslF345X05/form4-09252024_100900.xml Price: 236.52,...
EnGene Says Early Pivotal Data Show Detalimogene's 'Promising' Efficacy in Bladder Cancer
EnGene Says Early Pivotal Data Show Detalimogene's 'Promising' Efficacy in Bladder Cancer
Sep 26, 2024
10:25 AM EDT, 09/26/2024 (MT Newswires) -- EnGene Holdings ( ENGN ) said Thursday preliminary results from the pivotal cohort of an ongoing study demonstrated a 71% complete response rate at any time for its investigational product detalimogene voraplasmid in patients with BCG-unresponsive non-muscle invasive bladder cancer. The complete response rate was 67% at three months and 47% at six...
Slow Airbus deliveries raise fresh questions over annual target
Slow Airbus deliveries raise fresh questions over annual target
Sep 26, 2024
* Airbus Sept deliveries seen well below same month last year * Cirium Ascend analyst casts doubt on annual delivery target * Flat production heightens focus on saving cash, sources say * Airbus lowered target in July, aims for 'around 770' deliveries By Tim Hepher PARIS, Sept 26 (Reuters) - Airbus deliveries are closing September at a slower pace than...
Copyright 2023-2026 - www.financetom.com All Rights Reserved